Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07211438) titled 'Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression' on Oct. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Centre for Addiction and Mental Health
Condition:
Treatment-Resistant Depression
Intervention:
Drug: Psilocybin
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 1, 2026
Target Sample Size: 40
Countries of Recruitment:
Canada
To kn...